Over a week ago |
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 02/08/23
- Qualtrics CEO sells $2.27M in common stock
- 01/11/23
- Qualtrics to eliminate 270 roles, less than 5% of workforce
WBA Walgreens Boots Alliance - 03/06/23
- California 'done' with Walgreens over abortion pill stance
- 03/02/23
- Walgreens with DoorDash, Uber announce free Same Day Rx Delivery for HIV
- 02/21/23
- NCR expands ATM presence and services at Walgreens' U.S. stores
- 02/01/23
- Rackspace Technology appoints Roberts to board of directors
- 03/06/23
- Vistra rises 14.5%
- 03/06/23
- Vistra rises 10.8%
- 03/06/23
- Vistra to continue to repurchase $1B of stock in 2025, 2026
- 03/06/23
- Vistra raises aggregate share repurchase authorization by $1B
- 02/23/23
- Vir Biotechnology shares fall over 5% after missing quarterly estimates
- 02/22/23
- Vir Biotechnology announces final draft guidance on sotrovimab from U.K.'s NICE
- 02/16/23
- Vir Biotechnology appoints Sung Lee as Chief Financial Officer
- 02/13/23
- Vir Biotechnology announces amended collaboration pact with GSK
- 03/03/23
- Valaris to replace FICO in S&P 400 at open on 3/20
- 12/15/22
- Valaris announces contract awards with backlog of roughly $275M
- 11/21/22
- Valaris announces contract award for drillship VALARIS DS-12
- 11/14/22
- Elliott made Triple Flag Precious Metals top holding during Q3
- 11/01/22
- Sirius XM continues to expect positive 2022 self-pay net subscriber additions
- 11/01/22
- Sirius XM reports Q3 self-pay subscribers 32.3M
- 11/01/22
- Sirius XM raises quarterly cash dividend 10%
- 10/31/22
- Sirius XM to be standard in-dash feature across full lineup of Lucid vehicles
- 03/06/23
- Silvergate Capital falls -9.6%
- 03/06/23
- Silvergate falls after discontinuing Silvergate Exchange Network
- 03/03/23
- Silvergate Capital falls -6.4%
- 03/02/23
- Silvergate Capital falls -44.7%
- 02/15/23
- Spirit Airlines announces five new, nonstop routes from San Juan
- 02/06/23
- Spirit Airlines sees FY23 ASM up 19%-22%
- 03/06/23
- Silver Lake offers $18.15 per share in cash for Qualtrics
- 02/22/23
- SAP proposes dividend of EUR2.05 per share
- 02/22/23
- SAP supervisory board proposes Renjen as designated successor to chairman
- 02/01/23
- Qualtrics up 5% after Silver Lake says intends to submit bid
- 03/06/23
- Lordstown Motors expects to end Q1 with $150M-$170M in cash
- 02/23/23
- Lordstown Motors files for voluntary recall of Endurance
- 02/23/23
- Lordstown Motors pauses production, delivery to address quality issues
- 01/04/23
- Lordstown Motors says produced 31 Endurance vehicles through January 3
- $283.50 /
-13.79 (-4.64%) - 02/03/23
- RH says certain financial statements 'should no longer be relied upon'
- 02/03/23
- RH sees FY22 revenue growth at low end of prior range of (3.5%)-(4.5%)
- 12/08/22
- RH says Q3 gross margin contracted 50bps
- 12/08/22
- RH to acquire Dmitriy & Co
- 03/06/23
- ISS, Glass Lewis recommend Ritchie Bros. investors vote against IAA merger
- 03/06/23
- Ritchie Bros. board 'strongly disagrees' with Glass Lewis, ISS recommendations
- 03/03/23
- Ritchie Bros. receives support from large shareholders regarding IAA deal
- 03/03/23
- Ritchie Bros. urges shareholders to vote 'for' all proposals on White proxy card
- 10/12/22
- CJ 4DPlex says 'Top Gun: Maverick' grossed $60M in its premier formats
- 03/01/23
- User reports indicate problems at Paramount+, Downdetector says
- 02/16/23
- Paramount expects to raise Paramount+ price $2.00 on premium tier
- 02/16/23
- Paramount expects slower recovery in international ad market
- 02/16/23
- Paramount sees Q1 charge of $1.3B-$1.5B from Showtime, Paramount+ integration
- 03/06/23
- Altria Group to acquire NJOY Holdings for $2.75B in cash
- 03/03/23
- Altria Group exchanges minority stake in JUUL Labs for heated tobacco IP rights
- 01/24/23
- Altria Group trading resumes
- 01/24/23
- Altria Group trading halted, volatility trading pause
- $103.99 /
+1.995 (+1.96%) - 02/28/23
- Monster Beverage announces 2-for-1 split, effective March 28
- 11/03/22
- Monster Beverage announces new $500M share repurchase program
- 10/27/22
- MSG Sports, MSG Entertainment enter marketing partnership with Monster Energy
- 10/10/22
- VPX Sports, maker of Bang Energy drinks, seeks Chapter 11 bankruptcy protection
- 03/06/23
- JetBlue says updated data supports 'pro-competitive impact' of Spirit merger
- 03/06/23
- Spirit Airlines falls after Bloomberg report of DOJ merger lawsuit
- 03/01/23
- JetBlue announces appointment of Keith Anderson as CISO
- 02/28/23
- JetBlue Travel Products teams with Briggs & Riley and Solo on Paisly
- 03/05/23
- Esperion announced full results from landmark CLEAR outcomes study
- 01/11/23
- RFK Racing enters team-wide partnership with Esperion
- 12/07/22
- Esperion announces CLEAR cardiovascular outcomes trial of NEXLETOL
- 11/16/22
- Esperion promotes Ben Halladay to CFO role
- 03/06/23
- Vistra to acquire Energy Harbor for $3B in cash
- 11/08/22
- Great Lakes Clean Hydrogen Partnership moves forward with DOE application
- 03/06/23
- Ciena expects to repurchase $250M shares this FY
- 03/06/23
- Ciena sees inventory lower in 4Q23 vs. 4Q22
- 03/06/23
- Ciena on track to achieve three year revenue CAGR outlook of 10%-12%, says CEO
- 03/06/23
- Ciena CEO: WaveLogic 6 to support up to 1.6Tbps single carrier wavelengths
- 01/10/23
- CECO Environmental completes Wakefield Acoustics acquisition
- 01/10/23
- CECO Environmental expects Q4 orders to exceed $145M
- 02/07/23
- Caterpillar director Dickinson sells 6,070 common shares
- 01/31/23
- Caterpillar expects healthy mining demand
- 01/31/23
- Caterpillar: Pockets of supply chain challenges remain
- 01/06/23
- Caterpillar to invest in Lithos Energy
- 03/06/23
- BlackLine announces leadership succession
- 12/08/22
- BlackLine to reduce global workforce by about 5%
- 11/07/22
- Officer of BlackLine Mark Woodhams sold over $227K in company shares
- 03/06/23
- BridgeBio announces Phase 2 cohort 5 results of infigratinib
- 02/23/23
- BridgeBio sees cash runway into 2024
- 02/17/23
- BridgeBio reports inducement grants under Nasdaq listing rule
- 12/22/22
- BridgeBio initiates Phase 3 trial CALIBRATE study of encaleret
- 03/05/23
- Fly Intel: Top five weekend stock stories
- 03/03/23
- JBG Smith says first phase of Amazon headquarters remains on schedule
- 03/03/23
- JBG Smith Properties down 7% after Amazon pauses HQ construction
- 03/02/23
- Amazon announces launch of 3-Way Match
- 03/06/23
- Kerrisdale Capital short C3.ai on 'poor customer traction,' financial pressures
- 03/03/23
- C3.ai rises 27.5%
- 03/03/23
- C3.ai rises 17.9%
- 03/03/23
- C3.ai rises 14.7%
ACRS Aclaris Therapeutics - 03/06/23
- Aclaris Therapeutics announces preliminary data from Phase 2 study of ATI-450
- 01/06/23
- Aclaris Therapeutics provides corporate outlook for 2023
- 11/29/22
- Aclaris, Pediatrix announce license agreement for ATI-1777 in greater China
- 11/22/22
- Aclaris names Dr. Neal Walker board chair, Doug Manion to transition to CEO role
- 02/28/23
- Globalstar spikes 10% after disclosing $252M loan from Apple
- 02/22/23
- Apple prepares to allow outside app stores or 'sideloading,' Bloomberg reports
- 02/16/23
- T-Mobile announces launch of MLS Season Pass on Apple TV app
- 02/14/23
- Berkshire added more of top-holding Apple, Paramount in Q4
- 11/10/22 UBS
- UBS downgrades Altria to Sell on consumer trade down risk
- 11/10/22 UBS
- Altria Group downgraded to Sell from Neutral at UBS
- 11/02/22 Morgan Stanley
- Philip Morris price target raised to $109 from $102 at Morgan Stanley
- 10/28/22 Stifel
- Altria JV news trumps 'rare' EPS miss, says Stifel
- 03/06/23 Compass Point
- Silvergate Capital downgraded to Sell from Neutral at Compass Point
- 03/06/23 Wedbush
- Wedbush downgrades Silvergate Capital to Underperform, lowers price target to $4
- 03/06/23 Wedbush
- Silvergate Capital downgraded to Underperform from Neutral at Wedbush
- 03/02/23 Goldman Sachs
- Goldman suspends Silvergate rating on 'insufficient information'
- 03/01/23 Lake Street
- Clean Energy price target lowered to $22 from $27 at Lake Street
- 02/23/23 DA Davidson
- Etsy price target raised to $161 from $121 at DA Davidson
- 02/16/23 MoffettNathanson
- RingCentral price target lowered to $52 from $55 at MoffettNathanson
- 02/14/23 Loop Capital
- Amazon.com retail business showing progress toward recovery, says Loop Capital
- 01/27/23 Wolfe Research
- JetBlue price target raised to $7 from $6 at Wolfe Research
- 12/20/22 Deutsche Bank
- JetBlue price target lowered to $8.50 from $10 at Deutsche Bank
- 12/20/22 Deutsche Bank
- Spirit Airlines downgraded on regulatory process at Deutsche Bank
- 12/16/22 Goldman Sachs
- JetBlue resumed with a Not Rated at Goldman Sachs
- 12/20/22 Deutsche Bank
- Spirit Airlines downgraded to Hold from Buy at Deutsche Bank
- 11/01/22 Citi
- Spirit Airlines price target raised to $23 from $22 at Citi
- 09/30/22 Citi
- Spirit Airlines reinstated with a Neutral at Citi (yesterday)
WBA Walgreens Boots Alliance - 02/23/23 Loop Capital
- Loop Capital starts Walgreens Boots at Buy, sees higher growth from healthcare
- 02/22/23 Loop Capital
- Walgreens Boots Alliance initiated with a Buy at Loop Capital
- 01/31/23 UBS
- AmerisourceBergen price target raised to $190 from $184 at UBS
- 01/19/23 Truist
- Walgreens Boots Alliance price target lowered to $42 from $44 at Truist
- 03/03/23 Morgan Stanley
- SAP price target raised to EUR 135 from EUR 123 at Morgan Stanley
- 02/01/23 Berenberg
- SAP price target raised to EUR 125 from EUR 110 at Berenberg
- 02/01/23 Baader Helvea
- SAP downgraded to Add from Buy at Baader Helvea
- 01/27/23 Barclays
- SAP price target lowered to EUR 125 from EUR 130 at Barclays
- 03/06/23 BofA
- Apple App Store revenue growth 'still muted' in fiscal Q2-to-date, says BofA
- 03/05/23 Goldman Sachs
- Apple initiated with a Buy at Goldman Sachs
- 03/03/23 Barclays
- Google facing query share loss for first time ever, says Barclays
- 03/03/23 Morgan Stanley
- Morgan Stanley sees catalysts for top pick Apple, ups price target
- $103.99 /
+1.995 (+1.96%) - 03/06/23 Redburn
- Monster Beverage upgraded to Buy from Neutral at Redburn
- 03/01/23 BMO Capital
- Monster Beverage price target raised to $105 from $97 at BMO Capital
- 03/01/23 Truist
- Monster Beverage price target raised to $120 from $100 at Truist
- 03/01/23 Citi
- Monster Beverage price target lowered to $118 from $121 at Citi
- 03/06/23 H.C. Wainwright
- Vir Biotechnology price target lowered to $100 from $125 at H.C. Wainwright
- 03/06/23 JPMorgan
- Vir Biotechnology upgraded to Overweight from Neutral at JPMorgan
- 02/21/23 Goldman Sachs
- Vir Biotechnology upgraded to Buy from Neutral at Goldman Sachs
- 01/27/23 Morgan Stanley
- Vir Biotechnology upgraded to Equal Weight from Underweight at Morgan Stanley
- $283.50 /
-13.79 (-4.64%) - 03/06/23 Jefferies
- RH cut to Hold at Jefferies with luxury housing market 'struggling to stabilize'
- 03/06/23 Jefferies
- RH downgraded to Hold from Buy at Jefferies
- 02/07/23 Barclays
- Barclays sees a 'reset' in U.S. retail but 'not a recession yet'
- 02/07/23 Barclays
- RH assumed with an Equal Weight at Barclays
- 01/24/23 Raymond James
- Ritchie Bros. price target raised to $60 from $55 at Raymond James
- 01/24/23 Baird
- Ritchie Bros. price target raised to $66 from $62 at Baird
- 01/05/23 Baird
- IAA downgraded to Neutral from Outperform at Baird
- 12/05/22 Scotiabank
- Ritchie Bros. upgraded to Outperform at Scotiabank after deal-driven pullback
- 03/06/23 Citi
- Liberty SiriusXM price target lowered to $46 from $62 at Citi
- 02/22/23 Rosenblatt
- Sirius XM downgraded to Neutral at Rosenblatt amid new questions about growth
- 02/22/23 Rosenblatt
- Sirius XM downgraded to Neutral from Buy at Rosenblatt
- 02/09/23 Pivotal Research
- Sirius XM price target lowered to $5 from $6.75 at Pivotal Research
- 03/03/23 Deutsche Bank
- C3.ai price target raised to $16 from $11 at Deutsche Bank
- 03/03/23 Piper Sandler
- C3.ai price target raised to $23 from $13 at Piper Sandler
- 03/03/23 Canaccord
- C3.ai price target raised to $21 from $14 at Canaccord
- 03/03/23 Wedbush
- C3.ai price target raised to $24 from $13 at Wedbush
- 02/23/23 Baird
- Baird says Caterpillar should consider acquisition of Agco
- 02/23/23 Baird
- Caterpillar should consider acquiring Agco, says Baird
- 02/13/23 Baird
- Caterpillar downgraded to Neutral from Outperform at Baird
- 02/07/23 BMO Capital
- Caterpillar price target raised to $230 from $210 at BMO Capital
- 01/31/23 Macquarie
- Paramount downgraded to Underperform at Macquarie on high ad exposure
- 01/31/23 Macquarie
- Paramount downgraded to Underperform from Neutral at Macquarie
- 01/12/23 Guggenheim
- Paramount price target raised to $22 from $20 at Guggenheim
- 01/04/23 Macquarie
- Paramount price target lowered to $15 from $16 at Macquarie
- 03/07/23 BofA
- Ascendis Pharma has positive read-through from BridgeBio data, says BofA
- 03/07/23 BofA
- Tyra Biosciences has positive read-through from BridgeBio data, says BofA
- 03/07/23 BofA
- BridgeBio price target raised to $18 from $15 at BofA
- 03/06/23 Oppenheimer
- Opco views BridgeBio data as good news for Tyra Biosciences
- 03/06/23 William Blair
- William Blair downgrades Qualtrics, sees higher bid as unlikely
- 03/06/23 William Blair
- Qualtrics downgraded to Market Perform from Outperform at William Blair
- 03/06/23 BMO Capital
- Qualtrics downgraded to Market Perform from Outperform at BMO Capital
- 03/06/23 Evercore ISI
- Evercore downgrades Qualtrics, sees 'limited' upside after Silver Lake bid
ACRS Aclaris Therapeutics - 03/07/23 BTIG
- Aclaris Therapeutics price target lowered to $29 from $32 at BTIG
- 03/07/23 H.C. Wainwright
- Aclaris Therapeutics price target lowered to $43 from $50 at H.C. Wainwright
- 12/28/22 Cantor Fitzgerald
- Cantor calls Merck top large cap pharma pick, names 8 SMID cap top picks
- 12/13/22 Stifel
- Aclaris Therapeutics initiated with a Buy at Stifel
- 03/07/23 Credit Suisse
- Esperion upgraded to Neutral from Underperform at Credit Suisse
- 02/27/23 BofA
- Esperion reinstated with a Neutral at BofA
- 02/24/23 Jefferies
- Esperion assumed at Buy from Hold at Jefferies
- 02/03/23 Morgan Stanley
- Esperion upgraded to Equal Weight from Underweight at Morgan Stanley
- 03/07/23 B. Riley
- Ciena price target raised to $72 from $69 at B. Riley
- 03/07/23 JPMorgan
- Ciena price target raised to $66 from $65 at JPMorgan
- 03/07/23 Barclays
- Ciena price target raised to $74 from $71 at Barclays
- 01/02/23 Rosenblatt
- Rosenblatt reveals 15 best stock ideas for 2023
- 02/15/23 BMO Capital
- BlackLine price target lowered to $71 from $76 at BMO Capital
- 02/15/23 Truist
- BlackLine price target raised to $65 from $55 at Truist
- 02/15/23 Baird
- BlackLine price target raised to $82 from $72 at Baird
- 02/15/23 Citi
- BlackLine price target raised to $65 from $63 at Citi
- 02/22/23 Barclays
- Valaris price target lowered to $82 from $88 at Barclays
- 02/16/23 Barclays
- Valaris initiated with an Equal Weight at Barclays
- 01/25/23 BTIG
- Valaris price target raised to $90 from $80 at BTIG
- 01/19/23 Benchmark
- Valaris initiated with a Buy at Benchmark
- 01/11/23 Goldman Sachs
- Goldman continues to prefer Tesla and GM among automakers
- 08/05/22 R.F. Lafferty
- R.F. Lafferty keeps $1 target on Lordstown after Q2 results
- 05/10/22 R.F. Lafferty
- Lordstown Motors downgraded to Sell from Hold at R.F. Lafferty
- 05/10/22 Deutsche Bank
- Lordstown Motors price target lowered to $2 from $3 at Deutsche Bank
- 03/07/23 H.C. Wainwright
- Ceco Environmental price target raised to $22 from $15 at H.C. Wainwright
- 01/20/23 Craig-Hallum
- CECO Environmental price target raised to $19 from $17 at Craig-Hallum
- 01/11/23 Needham
- CECO Environmental price target raised to $16 from $14 at Needham
- 01/25/23
- Qualtrics sees FY23 adjusted EPS 20c-24c, consensus 10c
- 01/25/23
- Qualtrics sees adjusted Q1 EPS 1c-2c, consensus 1c
- 01/25/23
- Qualtrics reports Q4 EPS 3c, consensus 2c
- 10/24/22
- Qualtrics raises FY22 EPS view to 4c-5c from (9c)-(7c), consensus (7c)
WBA Walgreens Boots Alliance - 01/05/23
- Walgreens Boots Alliance backs FY23 adjusted EPS view $4.45-$4.65
- 01/05/23
- Walgreens Boots Alliance reports Q1 adjusted EPS $1.16, consensus $1.13
- 01/04/23
- Notable companies reporting before tomorrow's open
- 11/04/22
- Vistra reports Q3 revenue $5.15B, consensus $7.53B
- 02/23/23
- Vir Biotechnology reports Q4 EPS (76c), consensus (39c)
- 11/03/22
- Vir Biotechnology reports Q3 EPS $1.30, consensus (21c)
- 03/06/23
- Valaris sees FY23 revenue $1.8B-$1.9B, consensus $1.8B
- 03/06/23
- Valaris sees Q1 adjusted EBITDA approximately $5M
- 03/06/23
- Valaris sees Q1 adjusted EBITDA approximately $5M
- 02/21/23
- Valaris reports Q4 EPS 38c, consensus 46c
- 02/02/23
- Sirius XM sees FY23 revenue $9.0B, consensus $9.29B
- 02/02/23
- Sirius XM reports Q4 EPS 9c, consensus 8c
- 02/01/23
- Notable companies reporting before tomorrow's open
- 01/17/23
- Silvergate Capital reports Q4 adjusted EPS 48c, consensus 81c
- 10/18/22
- Silvergate Capital reports Q3 EPS $1.28, consensus $1.38
- 02/06/23
- Spirit Airlines reports Q4 adjusted EPS 12c, consensus 4c
- 02/06/23
- Notable companies reporting after market close
- 10/26/22
- Spirit Airlines reports Q3 adjusted EPS 3c, consensus (10c)
- 10/26/22
- Notable companies reporting after market close
- 01/26/23
- SAP reports Q4 EPS EUR 1.00 vs. EUR 1.85 last year
- 10/25/22
- SAP reports Q3 EPS EUR 1.12 vs. EUR 1.74 last year
- 03/06/23
- Lordstown Motors reports Q4 EPS (45c) vs. (42c) last year
- 11/08/22
- Lordstown Motors reports Q3 EPS (73c) vs. (54c) a year ago
- $283.50 /
-13.79 (-4.64%) - 12/08/22
- RH narrow FY22 revenue growth view to down 4.5% to down 3.5%
- 12/08/22
- RH reports Q3 EPS $5.67, consensus $4.70
- 12/08/22
- Notable companies reporting after market close
- 09/08/22
- RH sees Q3 revenue down 18% to down 15%
- 02/21/23
- Ritchie Bros. reports Q4 adjusted EPS 68c, consensus 60c
- 02/13/23
- Ritchie Bros. sees Q4 revenue $444M, consensus $410.57M
- 11/07/22
- Ritchie Bros. reports Q3 adjusted EPS 53c, consensus 49c
- 02/16/23
- Paramount sees Q1 OIBDA similar to Q4; expects a Q1 EPS loss
- 02/16/23
- Paramount reports Q4 adjusted EPS 8c, consensus 24c
- 02/15/23
- Notable companies reporting before tomorrow's open
- 02/01/23
- Altria Group sees FY23 adjusted EPS $4.98-$5.13, consensus $5.05
- 02/01/23
- Altria Group reports Q4 adjusted EPS $1.18, consensus $1.17
- 01/31/23
- Notable companies reporting before tomorrow's open
- $103.99 /
+1.995 (+1.96%) - 02/28/23
- Monster Beverage reports Q4 EPS 57c, consensus 63c
- 02/28/23
- Notable companies reporting after market close
- 11/03/22
- Monster Beverage reports Q3 EPS 60c, consensus 59c
- 11/03/22
- Notable companies reporting after market close
- 01/26/23
- JetBlue sees Q1 EPS (45c)-(35c), consensus (4c)
- 01/26/23
- JetBlue Sees FY23 Adj EPS 70c- $1.00, consensus 67c
- 01/26/23
- JetBlue reports Q4 EPS 22c, consensus 20c
- 01/25/23
- Notable companies reporting before tomorrow's open
- 02/21/23
- IAA reports Q4 adjusted EPS 61c, consensus 54c
- 02/13/23
- IAA reports preliminary Q4 revenue $524M, consensus $535.21M
- 11/07/22
- IAA reports Q3 adjusted EPS 45c, consensus 50c
- 02/21/23
- Esperion reports Q4 EPS (76c), consensus (84c)
- 01/08/23
- Esperion reports preliminary Q4 revenue $14.4M-$15.1M, consensus $21.07M
- 11/01/22
- Esperion reports Q3 EPS (81c), consensus (92c)
- 03/06/23
- Ciena now sees FY23 revenue up 20%-22% y/y, up from 16%-18% y/y
- 03/06/23
- Ciena sees Q2 revenue $1.035B-$1.115B, consensus $1.04B
- 03/06/23
- Ciena reports Q1 adjusted EPS 64c, consensus 36c
- 12/08/22
- Ciena sees Q1 revenue $910M-$990M, consensus $871.03M
- 03/06/23
- CECO Environmental raises FY23 revenue view to $460M-$485M from $450M-$475M
- 03/06/23
- CECO Environmental reports Q4 adjusted EPS 21c, consensus 16c
- 01/31/23
- Caterpillar reports Q4 adjusted EPS $3.86, consensus $4.02
- 01/30/23
- Notable companies reporting before tomorrow's open
- 10/27/22
- Caterpillar reports Q3 adjusted EPS $3.95, consensus $3.16
- 03/06/23
- BlackLine reaffirms view FY23 EPS 89c-94c, consensus 92c
- 03/06/23
- BlackLine reaffirms Q1 EPS 15c-17c, consensus 16c
- 02/14/23
- BlackLine sees FY23 EPS 89c-94c, consensus 57c
- 02/14/23
- BlackLine sees Q1 EPS 15c-17c, consensus 11c
- 02/23/23
- BridgeBio reports Q4 EPS (92c), consensus (85c)
- 11/03/22
- BridgeBio reports Q3 EPS (93c), consensus (99c)
- 02/02/23
- Amazon sees Q1 revenue $121B-$126B, consensus $125.11B
- 02/02/23
- Amazon reports Q4 EPS 3c with Rivian loss, consensus 17c
- 02/02/23
- Notable companies reporting after market close
- 10/27/22
- Amazon sees Q4 revenue $140B-$148B, consensus $155.15B
- 03/02/23
- C3.ai sees FY23 revenue $264M-$266M, consensus $261.3M
- 03/02/23
- C3.ai sees Q4 revenue $70M-$72M, consensus $69.85M
- 03/02/23
- C3.ai reports Q3 adjusted EPS (6c), consensus (22c)
- 03/02/23
- Notable companies reporting after market close
ACRS Aclaris Therapeutics - 02/23/23
- Aclaris Therapeutics reports Q4 EPS (41c), consensus (45c)
- 11/08/22
- Aclaris Therapeutics reports Q3 EPS (30c), consensus (40c)
- 02/02/23
- Apple reports Q1 EPS $1.88, consensus $1.94
- 10/27/22
- Apple reports Q4 EPS $1.29, consensus $1.17
- 10/27/22
- Notable companies reporting after market close
WBA Walgreens Boots Alliance - 03/03/23
- Walgreens will not distribute abortion pills in 20 states, Reuters report
- 01/25/23
- Walgreens weighing sale of $2B pharmacy automation business, Bloomberg says
- 01/19/23
- Rite Aid plans to provide abortion pill in some stores, Bloomberg reports
- 01/18/23
- West Virginia reaches $83M opioid settlement with Walgreens, AP reports
- 09/16/22
- WHO panel recommends against GSK, Regeneron COVID drugs, Bloomberg reports
- 03/06/23
- Sirius XM laying off 8% of workforce, The Hollywood Reporter says
- 12/01/22
- Sirius XM to cut staff amid faltering sales growth, Bloomberg reports
- 12/01/22
- Sirius XM to reduce staff in coming weeks, Bloomberg reports
- 03/03/23
- Silvergate Capital suspending Silvergate exchange network, Bloomberg says
- 03/03/23
- FHLB says Silvergate advances 'fully repaid,' American Banker reports
- 03/02/23
- Coinbase, Galaxy drop Silvergate after going concern filing, Reuters reports
- 02/16/23
- Binance had secret access to U.S. partner account at Silvergate, Reuters says
- 01/12/23
- More flights delayed, canceled on Thursday after Notam glitch, WSJ reports
- 01/26/23
- SAP plans to cut 3,000 jobs following steep profit decline in 2022, WSJ reports
- 10/24/22
- SAP delays Russia exit as deal discussions fail, Reuters reports
- 11/12/22
- EV stocks face a reckoning, not all will survive, Barron's says
- 11/08/22
- Foxconn plans $170M investment in Lordstown Motors
- 03/06/23
- Proxy advisors urging shareholders to reject Ritchie Bros' IAA bid, Reuters says
- 01/10/23
- Paramount+ orders live-action show based on 'Dungeons & Dragons,' TC says
- 09/13/22
- Paramount weighs merging Showtime streaming service into Paramount+, WSJ says
- 03/06/23
- Paramount exploring sale of BET majority stake, WSJ reports
- 02/28/23
- Paramount turned down over $3B offer for Showtime, WSJ reports
- 02/28/23
- Paramount turned down over $3B offer for Showtime, WSJ reports
- 02/27/23
- Warner Bros. Discovery sues Paramount over 'South Park,' WSJ reports
- 02/27/23
- Altria in advanced talks to buy NJOY for at least $2.75B, WSJ reports
- 02/27/23
- Altria in talks to acquire NJOY for at least $2.75B, WSJ reports
- 01/25/23
- Juul in deal discussions with Philip Morris, Altria, Japan Tobacco, WSJ says
- 01/21/23
- Wells Fargo, Disney among stocks watched by value investors, Barron's says
- $103.99 /
+1.995 (+1.96%) - 09/30/22
- Jury awards $293M in damages to Monster from rival Bang Energy, Reuters reports
- 03/06/23
- JetBlue bracing for DOJ to try to block Spirit takeover, WSJ reports
- 03/06/23
- DOJ to file antitrust suit against JetBlue, Spirit deal, Bloomberg reports
- 03/06/23
- JetBlue, Spirit to face DOJ suit over merger, Bloomberg reports
- 01/13/23
- FAA pilot-alert system Notam breaks down after warnings, WSJ reports
- 03/06/23
- Caterpillar won't close union plants under new contract, WSJ reports
- 11/17/22
- Caterpillar faces fine after worker incinerated in accident, NY Post reports
- 03/03/23
- Amazon pauses construction on second headquarters, Bloomberg reports
- 03/02/23
- ESPN looking to be hub of all live sports streaming, CNBC reports
- 02/26/23
- Amazon expands same-day delivery as it battles slow growth, WSJ says
- 02/21/23
- Amazon deal for 1Life won't be challenged by FTC, Bloomberg says
- 03/06/23
- Kerrisdale Capital says short C3.ai
- 03/03/23
- Apple executive in charge of cloud initiatives stepping down, Bloomberg reports
- 03/03/23
- Foxconn plans $700M investment in India plant, Bloomberg reports
- 03/02/23
- 2023 iPhone to be powered by TSMC's 3nm SoC, DigiTimes reports
WBA Walgreens Boots Alliance - 02/25/23
- Buy/Sell: Wall Street's top 10 stock calls this week
- 02/23/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/25/23
- What You Missed On Wall Street On Wednesday
- 01/19/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/22/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/02/23
- Fly Intel: Pre-market Movers
- 03/06/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 03/06/23
- Fly Intel: Pre-market Movers
- 02/06/23
- Fly Intel: After-Hours Movers
- 01/11/23
- What You Missed On Wall Street This Morning
- 10/24/22
- What You Missed On Wall Street On Monday
- 01/09/23
- What You Missed This Week in EVs and Clean Energy
- $283.50 /
-13.79 (-4.64%) - 02/06/23
- What You Missed On Wall Street On Monday
- 02/13/23
- What You Missed On Wall Street On Monday
- 02/13/23
- What You Missed On Wall Street This Morning
- 02/16/23
- What You Missed On Wall Street This Morning
- 02/14/23
- What You Missed On Wall Street On Tuesday
- 02/28/23
- What You Missed On Wall Street On Tuesday
- 02/27/23
- What You Missed On Wall Street This Morning
- 03/06/23
- What You Missed On Wall Street On Monday
- 03/06/23
- What You Missed On Wall Street This Morning
- 02/27/23
- What You Missed On Wall Street On Monday
- 02/01/23
- What You Missed On Wall Street On Wednesday
- $103.99 /
+1.995 (+1.96%) - 03/01/23
- What You Missed On Wall Street On Wednesday
- 01/26/23
- What You Missed On Wall Street On Thursday
- 01/26/23
- What You Missed On Wall Street This Morning
- 01/11/23
- What You Missed On Wall Street On Wednesday
- 02/24/23
- What You Missed On Wall Street On Friday
- 02/24/23
- What You Missed On Wall Street This Morning
- 12/20/22
- What You Missed On Wall Street On Tuesday
- 02/23/23
- What You Missed On Wall Street On Thursday
- 02/06/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 03/05/23
- Box Office Battle: ‘’Creed III’ wins weekend with historic $58.7M debut
- 03/03/23
- What You Missed On Wall Street On Friday
- 03/03/23
- Sell these stocks now, proven algorithm says
ACRS Aclaris Therapeutics - 02/06/23
- Fly Insider Express, ServiceNow among week's notable insider trades
- 02/01/23
- Unusually active option classes on open February 1st
WBA Walgreens Boots Alliance - 01/05/23
- Unusually active option classes on open January 5th
- 11/11/22
- Unusually active option classes on open November 11th
- 11/07/22
- Early notable gainers among liquid option names on November 7th
- 11/07/22
- Unusually active option classes on open November 7th
- 09/16/22
- Vistra Energy put volume heavy and directionally bearish
- 02/24/23
- Largest borrow rate increases among liquid names
- 02/10/23
- Largest borrow rate increases among liquid names
- 02/06/23
- Sirius XM call volume above normal and directionally bullish
- 02/01/23
- Sirius XM put volume heavy and directionally bearish
- 03/06/23
- Unusually active option classes on open March 6th
- 03/06/23
- Notable open interest changes for March 6th
- 03/03/23
- Notable open interest changes for March 3rd
- 02/15/23
- Silvergate Capital Corp call volume above normal and directionally bullish
- 03/01/23
- Spirit Airlines put volume heavy and directionally bearish
- 02/24/23
- Spirit Airlines put volume heavy and directionally bearish
- 02/22/23
- Spirit Airlines put volume heavy and directionally bearish
- 02/15/23
- Spirit Airlines put volume heavy and directionally bearish
- 11/01/22
- Largest borrow rate increases among liquid names
- 11/28/22
- Largest borrow rate increases among liquid names
- $283.50 /
-13.79 (-4.64%) - 02/08/23
- Largest borrow rate increases among liquid names
- 12/08/22
- Restoration Hardware options imply 7.8% move in share price post-earnings
- 10/24/22
- Restoration Hardware put volume heavy and directionally bearish
- 09/08/22
- Restoration Hardware options imply 7.3% move in share price post-earnings
- 02/21/23
- Ritchie Brothers Auctioneers options imply 6.2% move in share price post-earnings
- 02/13/23
- Largest borrow rate increases among liquid names
- 02/09/23
- Largest borrow rate increases among liquid names
- 12/13/22
- Largest borrow rate increases among liquid names
- 02/15/23
- Early notable gainers among liquid option names on February 15th
- 02/13/23
- Unusually active option classes on open February 13th
- 01/23/23
- Paramount Global call volume above normal and directionally bullish
- 01/04/23
- Heavy put volume in Paramount Global
- 12/27/22
- Altria Group put volume heavy and directionally bearish
- 10/11/22
- Altria Group call volume above normal and directionally bullish
- 10/11/22
- Early notable gainers among liquid option names on October 11th
- 09/29/22
- Altria Group call volume above normal and directionally bullish
- $103.99 /
+1.995 (+1.96%) - 03/02/23
- Early notable gainers among liquid option names on March 2nd
- 12/16/22
- JetBlue call volume above normal and directionally bullish
- 12/13/22
- Unusually active option classes on open December 13th
- 11/14/22
- JetBlue put volume heavy and directionally bearish
- 10/20/22
- JetBlue call volume above normal and directionally bullish
- 01/06/23
- Esperion call volume above normal and directionally bullish
- 12/19/22
- Esperion put volume heavy and directionally bearish
- 12/07/22
- Unusually active option classes on open December 7th
- 11/17/22
- Largest borrow rate increases among liquid names
- 12/08/22
- Unusually active option classes on open December 8th
- 11/07/22
- Two new option listings on November 7th
- 01/31/23
- Unusually active option classes on open January 31st
- 01/30/23
- Caterpillar put volume heavy and directionally bearish
- 12/21/22
- Unusually active option classes on open December 21st
- 11/23/22
- Unusually active option classes on open November 23rd
- 03/03/23
- Amazon call buyer realizes 11% same-day gains
- 03/02/23
- Notable open interest changes for March 2nd
- 02/27/23
- Notable open interest changes for February 27th
- 03/02/23
- C3 AI options imply 12.3% move in share price post-earnings
- 02/15/23
- C3 AI call volume above normal and directionally bullish
- 02/14/23
- C3 AI call volume above normal and directionally bullish
- 02/10/23
- Unusually active option classes on open February 10th
- 03/01/23
- Notable open interest changes for March 1st
- 02/28/23
- Notable open interest changes for February 28th
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 03/06/23
- Silver Lake offers $18.15 per share in cash for Qualtrics
- 02/08/23
- Qualtrics CEO sells $2.27M in common stock
- 02/01/23
- Qualtrics up 5% after Silver Lake says intends to submit bid
- 01/11/23
- Qualtrics to eliminate 270 roles, less than 5% of workforce
- 03/06/23
- Vistra rises 14.5%
- 03/06/23
- Vistra rises 10.8%
- 03/06/23
- Vistra to continue to repurchase $1B of stock in 2025, 2026
- 03/06/23
- Vistra raises aggregate share repurchase authorization by $1B
VRCA Verrica Pharmaceuticals - 02/27/23
- Verrica: FDA accepts filing of VP-102 resubmitted NDA for molluscum treatment
- 01/24/23
- Verrica Pharmaceuticals resubmits NDA for VP-102 in molluscum contagiosum
- 01/04/23
- Verrica Pharmaceuticals announces technology transfer to Piramal Pharma
- 02/23/23
- Vir Biotechnology shares fall over 5% after missing quarterly estimates
- 02/22/23
- Vir Biotechnology announces final draft guidance on sotrovimab from U.K.'s NICE
- 02/16/23
- Vir Biotechnology appoints Sung Lee as Chief Financial Officer
- 02/13/23
- Vir Biotechnology announces amended collaboration pact with GSK
- 03/03/23
- Valaris to replace FICO in S&P 400 at open on 3/20
- 12/15/22
- Valaris announces contract awards with backlog of roughly $275M
- 11/21/22
- Valaris announces contract award for drillship VALARIS DS-12
- 11/14/22
- Elliott made Triple Flag Precious Metals top holding during Q3
- 01/31/23
- UBS: Starting 2023 from a position of strength
- 10/20/22
- UBS, Microsoft announce landmark expansion of cloud partnership
- 10/04/22
- UBS Securities fined $2.5M for regulation SHO violations by FINRA
- 09/27/22
- SEC charges 16 Wall Street firms with recordkeeping failures
- 11/01/22
- Sirius XM continues to expect positive 2022 self-pay net subscriber additions
- 11/01/22
- Sirius XM reports Q3 self-pay subscribers 32.3M
- 11/01/22
- Sirius XM raises quarterly cash dividend 10%
- 10/31/22
- Sirius XM to be standard in-dash feature across full lineup of Lucid vehicles
- 03/06/23
- Silvergate Capital falls -9.6%
- 03/06/23
- Silvergate falls after discontinuing Silvergate Exchange Network
- 03/03/23
- Silvergate Capital falls -6.4%
- 03/02/23
- Silvergate Capital falls -44.7%
- 02/22/23
- SAP proposes dividend of EUR2.05 per share
- 02/22/23
- SAP supervisory board proposes Renjen as designated successor to chairman
- 03/06/23
- Lordstown Motors expects to end Q1 with $150M-$170M in cash
- 02/23/23
- Lordstown Motors files for voluntary recall of Endurance
- 02/23/23
- Lordstown Motors pauses production, delivery to address quality issues
- 01/04/23
- Lordstown Motors says produced 31 Endurance vehicles through January 3
- 02/03/23
- RH says certain financial statements 'should no longer be relied upon'
- 02/03/23
- RH sees FY22 revenue growth at low end of prior range of (3.5%)-(4.5%)
- 12/08/22
- RH says Q3 gross margin contracted 50bps
- 12/08/22
- RH to acquire Dmitriy & Co
- 03/06/23
- Ritchie Bros. board 'strongly disagrees' with Glass Lewis, ISS recommendations
- 03/03/23
- Ritchie Bros. receives support from large shareholders regarding IAA deal
- 03/03/23
- Ritchie Bros. urges shareholders to vote 'for' all proposals on White proxy card
- 02/28/23
- Luxor Capital issues response to Ritchie Bros.'s 'deceptive claims'
- 03/06/23
- Altria Group to acquire NJOY Holdings for $2.75B in cash
- 03/03/23
- Altria Group exchanges minority stake in JUUL Labs for heated tobacco IP rights
- 01/24/23
- Altria Group trading resumes
- 01/24/23
- Altria Group trading halted, volatility trading pause
- 02/28/23
- Monster Beverage announces 2-for-1 split, effective March 28
- 11/03/22
- Monster Beverage announces new $500M share repurchase program
- 10/27/22
- MSG Sports, MSG Entertainment enter marketing partnership with Monster Energy
- 10/10/22
- VPX Sports, maker of Bang Energy drinks, seeks Chapter 11 bankruptcy protection
- 03/05/23
- Esperion announced full results from landmark CLEAR outcomes study
- 01/11/23
- RFK Racing enters team-wide partnership with Esperion
- 12/07/22
- Esperion announces CLEAR cardiovascular outcomes trial of NEXLETOL
- 11/16/22
- Esperion promotes Ben Halladay to CFO role
- 03/06/23
- Vistra to acquire Energy Harbor for $3B in cash
- 11/08/22
- Great Lakes Clean Hydrogen Partnership moves forward with DOE application
- 03/06/23
- Ciena expects to repurchase $250M shares this FY
- 03/06/23
- Ciena sees inventory lower in 4Q23 vs. 4Q22
- 03/06/23
- Ciena on track to achieve three year revenue CAGR outlook of 10%-12%, says CEO
- 03/06/23
- Ciena CEO: WaveLogic 6 to support up to 1.6Tbps single carrier wavelengths
- 01/10/23
- CECO Environmental completes Wakefield Acoustics acquisition
- 01/10/23
- CECO Environmental expects Q4 orders to exceed $145M
- 02/07/23
- Caterpillar director Dickinson sells 6,070 common shares
- 01/31/23
- Caterpillar expects healthy mining demand
- 01/31/23
- Caterpillar: Pockets of supply chain challenges remain
- 01/06/23
- Caterpillar to invest in Lithos Energy
- 03/06/23
- BlackLine announces leadership succession
- 12/08/22
- BlackLine to reduce global workforce by about 5%
- 11/07/22
- Officer of BlackLine Mark Woodhams sold over $227K in company shares
- 03/06/23
- BridgeBio announces Phase 2 cohort 5 results of infigratinib
- 02/23/23
- BridgeBio sees cash runway into 2024
- 02/17/23
- BridgeBio reports inducement grants under Nasdaq listing rule
- 12/22/22
- BridgeBio initiates Phase 3 trial CALIBRATE study of encaleret
- 03/06/23
- AST SpaceMobile enters teaming agreement with Fairwinds Technologies
- 02/09/23
- AST SpaceMobile announces collaboration with Saudi Arabia-based Zain KSA
- 02/08/23
- AST SpaceMobile enters non-binding MoU with TIM
- 12/15/22
- AST SpaceMobile, NASA sign joint deal to improve spaceflight safety
- 03/05/23
- Fly Intel: Top five weekend stock stories
- 03/03/23
- JBG Smith says first phase of Amazon headquarters remains on schedule
- 03/03/23
- JBG Smith Properties down 7% after Amazon pauses HQ construction
- 03/02/23
- Amazon announces launch of 3-Way Match
- 03/06/23
- Kerrisdale Capital short C3.ai on 'poor customer traction,' financial pressures
- 03/03/23
- C3.ai rises 27.5%
- 03/03/23
- C3.ai rises 17.9%
- 03/03/23
- C3.ai rises 14.7%
ACRS Aclaris Therapeutics - 03/06/23
- Aclaris Therapeutics announces preliminary data from Phase 2 study of ATI-450
- 01/06/23
- Aclaris Therapeutics provides corporate outlook for 2023
- 11/29/22
- Aclaris, Pediatrix announce license agreement for ATI-1777 in greater China
- 11/22/22
- Aclaris names Dr. Neal Walker board chair, Doug Manion to transition to CEO role
- $155.55 /
+4.465 (+2.96%) - 02/28/23
- Globalstar spikes 10% after disclosing $252M loan from Apple
- 02/22/23
- Apple prepares to allow outside app stores or 'sideloading,' Bloomberg reports
- 02/16/23
- T-Mobile announces launch of MLS Season Pass on Apple TV app
- 02/14/23
- Berkshire added more of top-holding Apple, Paramount in Q4
- 11/10/22 UBS
- UBS downgrades Altria to Sell on consumer trade down risk
- 11/10/22 UBS
- Altria Group downgraded to Sell from Neutral at UBS
- 11/02/22 Morgan Stanley
- Philip Morris price target raised to $109 from $102 at Morgan Stanley
- 10/28/22 Stifel
- Altria JV news trumps 'rare' EPS miss, says Stifel
- 01/02/23 Rosenblatt
- Rosenblatt reveals 15 best stock ideas for 2023
- 12/21/22 Citi
- Citi reveals top telecom equipment stock picks for 2023
- 12/20/22 JPMorgan
- Ciena upgraded to Overweight from Neutral at JPMorgan
- 12/09/22 B. Riley
- Ciena price target raised to $69 from $64 at B. Riley
- 03/06/23 Compass Point
- Silvergate Capital downgraded to Sell from Neutral at Compass Point
- 03/06/23 Wedbush
- Wedbush downgrades Silvergate Capital to Underperform, lowers price target to $4
- 03/06/23 Wedbush
- Silvergate Capital downgraded to Underperform from Neutral at Wedbush
- 03/02/23 Goldman Sachs
- Goldman suspends Silvergate rating on 'insufficient information'
- 03/06/23 Evercore ISI
- Evercore downgrades Qualtrics, sees 'limited' upside after Silver Lake bid
- 03/06/23 Evercore ISI
- Qualtrics downgraded to In Line from Outperform at Evercore ISI
- 02/06/23 Canaccord
- Qualtrics price target raised to $18 from $15 at Canaccord
- 02/01/23 Deutsche Bank
- Qualtrics downgraded to Hold from Buy at Deutsche Bank
- 03/03/23 Morgan Stanley
- SAP price target raised to EUR 135 from EUR 123 at Morgan Stanley
- 02/01/23 Berenberg
- SAP price target raised to EUR 125 from EUR 110 at Berenberg
- 02/01/23 Baader Helvea
- SAP downgraded to Add from Buy at Baader Helvea
- 01/27/23 Barclays
- SAP price target lowered to EUR 125 from EUR 130 at Barclays
- 03/01/23 Lake Street
- Clean Energy price target lowered to $22 from $27 at Lake Street
- 02/23/23 DA Davidson
- Etsy price target raised to $161 from $121 at DA Davidson
- 02/16/23 MoffettNathanson
- RingCentral price target lowered to $52 from $55 at MoffettNathanson
- 02/14/23 Loop Capital
- Amazon.com retail business showing progress toward recovery, says Loop Capital
- $155.55 /
+4.465 (+2.96%) - 03/06/23 BofA
- Apple App Store revenue growth 'still muted' in fiscal Q2-to-date, says BofA
- 03/05/23 Goldman Sachs
- Apple initiated with a Buy at Goldman Sachs
- 03/03/23 Barclays
- Google facing query share loss for first time ever, says Barclays
- 03/03/23 Morgan Stanley
- Morgan Stanley sees catalysts for top pick Apple, ups price target
- 03/06/23 Redburn
- Monster Beverage upgraded to Buy from Neutral at Redburn
- 03/01/23 BMO Capital
- Monster Beverage price target raised to $105 from $97 at BMO Capital
- 03/01/23 Truist
- Monster Beverage price target raised to $120 from $100 at Truist
- 03/01/23 Citi
- Monster Beverage price target lowered to $118 from $121 at Citi
- 03/06/23 H.C. Wainwright
- Vir Biotechnology price target lowered to $100 from $125 at H.C. Wainwright
- 03/06/23 JPMorgan
- Vir Biotechnology upgraded to Overweight from Neutral at JPMorgan
- 02/21/23 Goldman Sachs
- Vir Biotechnology upgraded to Buy from Neutral at Goldman Sachs
- 01/27/23 Morgan Stanley
- Vir Biotechnology upgraded to Equal Weight from Underweight at Morgan Stanley
- 03/06/23 Jefferies
- RH cut to Hold at Jefferies with luxury housing market 'struggling to stabilize'
- 03/06/23 Jefferies
- RH downgraded to Hold from Buy at Jefferies
- 02/07/23 Barclays
- Barclays sees a 'reset' in U.S. retail but 'not a recession yet'
- 02/07/23 Barclays
- RH assumed with an Equal Weight at Barclays
- 01/24/23 Raymond James
- Ritchie Bros. price target raised to $60 from $55 at Raymond James
- 01/24/23 Baird
- Ritchie Bros. price target raised to $66 from $62 at Baird
- 01/05/23 Baird
- IAA downgraded to Neutral from Outperform at Baird
- 12/05/22 Scotiabank
- Ritchie Bros. upgraded to Outperform at Scotiabank after deal-driven pullback
- 03/06/23 Citi
- Liberty SiriusXM price target lowered to $46 from $62 at Citi
- 02/22/23 Rosenblatt
- Sirius XM downgraded to Neutral at Rosenblatt amid new questions about growth
- 02/22/23 Rosenblatt
- Sirius XM downgraded to Neutral from Buy at Rosenblatt
- 02/09/23 Pivotal Research
- Sirius XM price target lowered to $5 from $6.75 at Pivotal Research
- 03/03/23 Deutsche Bank
- C3.ai price target raised to $16 from $11 at Deutsche Bank
- 03/03/23 Piper Sandler
- C3.ai price target raised to $23 from $13 at Piper Sandler
- 03/03/23 Canaccord
- C3.ai price target raised to $21 from $14 at Canaccord
- 03/03/23 Wedbush
- C3.ai price target raised to $24 from $13 at Wedbush
- 02/06/23 Deutsche Bank
- UBS price target raised to CHF 24 from CHF 22 at Deutsche Bank
- 02/03/23 Morgan Stanley
- UBS price target raised to CHF 23 from CHF 20 at Morgan Stanley
- 02/01/23 Barclays
- UBS price target raised to CHF 17 from CHF 15 at Barclays
- 02/01/23 RBC Capital
- UBS price target raised to CHF 24 from CHF 23 at RBC Capital
- 02/23/23 Baird
- Baird says Caterpillar should consider acquisition of Agco
- 02/23/23 Baird
- Caterpillar should consider acquiring Agco, says Baird
- 02/13/23 Baird
- Caterpillar downgraded to Neutral from Outperform at Baird
- 02/07/23 BMO Capital
- Caterpillar price target raised to $230 from $210 at BMO Capital
- 03/06/23 Oppenheimer
- Opco views BridgeBio data as good news for Tyra Biosciences
- 02/06/23 TD Cowen
- BridgeBio initiated with an Outperform at Cowen
- 08/24/22 Mizuho
- BridgeBio price target lowered to $23 from $25 at Mizuho
- 08/05/22 JPMorgan
- BridgeBio selloff on Alnylam readout overdone, says JPMorgan
- 11/23/22 Deutsche Bank
- AST SpaceMobile price target raised to $32 from $30 at Deutsche Bank
- 10/28/22 B. Riley
- AST SpaceMobile initiated with a Buy at B. Riley
- 10/19/22 Barclays
- AST SpaceMobile price target lowered to $15 from $29 at Barclays
- 08/17/22 Deutsche Bank
- AST SpaceMobile price target lowered to $30 from $31 at Deutsche Bank
ACRS Aclaris Therapeutics - 12/28/22 Cantor Fitzgerald
- Cantor calls Merck top large cap pharma pick, names 8 SMID cap top picks
- 12/13/22 Stifel
- Aclaris Therapeutics initiated with a Buy at Stifel
- 12/01/22 Goldman Sachs
- Aclaris Therapeutics initiated with a Buy at Goldman Sachs
- 10/06/22 BTIG
- Aclaris Therapeutics initiated with a Buy at BTIG
- 02/27/23 BofA
- Esperion reinstated with a Neutral at BofA
- 02/24/23 Jefferies
- Esperion assumed at Buy from Hold at Jefferies
- 02/03/23 Morgan Stanley
- Esperion upgraded to Equal Weight from Underweight at Morgan Stanley
- 12/07/22 H.C. Wainwright
- H.C. Wainwright bullish on Esperion as CLEAR Outcomes meets primary endpoint
- 02/15/23 BMO Capital
- BlackLine price target lowered to $71 from $76 at BMO Capital
- 02/15/23 Truist
- BlackLine price target raised to $65 from $55 at Truist
- 02/15/23 Baird
- BlackLine price target raised to $82 from $72 at Baird
- 02/15/23 Citi
- BlackLine price target raised to $65 from $63 at Citi
VRCA Verrica Pharmaceuticals - 02/13/23 RBC Capital
- RBC upgrades Verrica Pharmaceuticals to Outperform on improved VP-102 view
- 02/13/23 RBC Capital
- Verrica upgraded to Outperform from Sector Perform at RBC Capital
- 05/31/22 H.C. Wainwright
- Verrica Pharmaceuticals price target lowered to $12 from $20 at H.C. Wainwright
- 05/25/22 Needham
- Verrica Pharmaceuticals downgraded to Hold at Needham after CRL
- 01/20/23 Craig-Hallum
- CECO Environmental price target raised to $19 from $17 at Craig-Hallum
- 01/11/23 Needham
- CECO Environmental price target raised to $16 from $14 at Needham
- 02/22/23 Barclays
- Valaris price target lowered to $82 from $88 at Barclays
- 02/16/23 Barclays
- Valaris initiated with an Equal Weight at Barclays
- 01/25/23 BTIG
- Valaris price target raised to $90 from $80 at BTIG
- 01/19/23 Benchmark
- Valaris initiated with a Buy at Benchmark
- 01/11/23 Goldman Sachs
- Goldman continues to prefer Tesla and GM among automakers
- 08/05/22 R.F. Lafferty
- R.F. Lafferty keeps $1 target on Lordstown after Q2 results
- 05/10/22 R.F. Lafferty
- Lordstown Motors downgraded to Sell from Hold at R.F. Lafferty
- 05/10/22 Deutsche Bank
- Lordstown Motors price target lowered to $2 from $3 at Deutsche Bank
- 01/25/23
- Qualtrics sees FY23 adjusted EPS 20c-24c, consensus 10c
- 01/25/23
- Qualtrics sees adjusted Q1 EPS 1c-2c, consensus 1c
- 01/25/23
- Qualtrics reports Q4 EPS 3c, consensus 2c
- 10/24/22
- Qualtrics raises FY22 EPS view to 4c-5c from (9c)-(7c), consensus (7c)
- 11/04/22
- Vistra reports Q3 revenue $5.15B, consensus $7.53B
VRCA Verrica Pharmaceuticals - 03/06/23
- Verrica Pharmaceuticals reports Q4 EPS (14c), consensus (19c)
- 11/07/22
- Verrica Pharmaceuticals reports Q3 EPS 7c, consensus (11c)
- 02/23/23
- Vir Biotechnology reports Q4 EPS (76c), consensus (39c)
- 11/03/22
- Vir Biotechnology reports Q3 EPS $1.30, consensus (21c)
- 03/06/23
- Valaris sees FY23 revenue $1.8B-$1.9B, consensus $1.8B
- 03/06/23
- Valaris sees Q1 adjusted EBITDA approximately $5M
- 03/06/23
- Valaris sees Q1 adjusted EBITDA approximately $5M
- 02/21/23
- Valaris reports Q4 EPS 38c, consensus 46c
- 01/31/23
- UBS reports Q4 EPS 50c, profit before tax $1.9B
- 10/25/22
- UBS reports Q3 EPS 52c, net profit $1.7B
- 02/02/23
- Sirius XM sees FY23 revenue $9.0B, consensus $9.29B
- 02/02/23
- Sirius XM reports Q4 EPS 9c, consensus 8c
- 02/01/23
- Notable companies reporting before tomorrow's open
- 01/17/23
- Silvergate Capital reports Q4 adjusted EPS 48c, consensus 81c
- 10/18/22
- Silvergate Capital reports Q3 EPS $1.28, consensus $1.38
- 01/26/23
- SAP reports Q4 EPS EUR 1.00 vs. EUR 1.85 last year
- 10/25/22
- SAP reports Q3 EPS EUR 1.12 vs. EUR 1.74 last year
- 03/06/23
- Lordstown Motors reports Q4 EPS (45c) vs. (42c) last year
- 11/08/22
- Lordstown Motors reports Q3 EPS (73c) vs. (54c) a year ago
- 12/08/22
- RH narrow FY22 revenue growth view to down 4.5% to down 3.5%
- 12/08/22
- RH reports Q3 EPS $5.67, consensus $4.70
- 12/08/22
- Notable companies reporting after market close
- 09/08/22
- RH sees Q3 revenue down 18% to down 15%
- 02/21/23
- Ritchie Bros. reports Q4 adjusted EPS 68c, consensus 60c
- 02/13/23
- Ritchie Bros. sees Q4 revenue $444M, consensus $410.57M
- 11/07/22
- Ritchie Bros. reports Q3 adjusted EPS 53c, consensus 49c
- 02/01/23
- Altria Group sees FY23 adjusted EPS $4.98-$5.13, consensus $5.05
- 02/01/23
- Altria Group reports Q4 adjusted EPS $1.18, consensus $1.17
- 01/31/23
- Notable companies reporting before tomorrow's open
- 02/28/23
- Monster Beverage reports Q4 EPS 57c, consensus 63c
- 02/28/23
- Notable companies reporting after market close
- 11/03/22
- Monster Beverage reports Q3 EPS 60c, consensus 59c
- 11/03/22
- Notable companies reporting after market close
- 02/21/23
- IAA reports Q4 adjusted EPS 61c, consensus 54c
- 02/13/23
- IAA reports preliminary Q4 revenue $524M, consensus $535.21M
- 11/07/22
- IAA reports Q3 adjusted EPS 45c, consensus 50c
- 02/21/23
- Esperion reports Q4 EPS (76c), consensus (84c)
- 01/08/23
- Esperion reports preliminary Q4 revenue $14.4M-$15.1M, consensus $21.07M
- 11/01/22
- Esperion reports Q3 EPS (81c), consensus (92c)
- 03/06/23
- Ciena now sees FY23 revenue up 20%-22% y/y, up from 16%-18% y/y
- 03/06/23
- Ciena sees Q2 revenue $1.035B-$1.115B, consensus $1.04B
- 03/06/23
- Ciena reports Q1 adjusted EPS 64c, consensus 36c
- 12/08/22
- Ciena sees Q1 revenue $910M-$990M, consensus $871.03M
- 03/06/23
- CECO Environmental raises FY23 revenue view to $460M-$485M from $450M-$475M
- 03/06/23
- CECO Environmental reports Q4 adjusted EPS 21c, consensus 16c
- 01/31/23
- Caterpillar reports Q4 adjusted EPS $3.86, consensus $4.02
- 01/30/23
- Notable companies reporting before tomorrow's open
- 10/27/22
- Caterpillar reports Q3 adjusted EPS $3.95, consensus $3.16
- 03/06/23
- BlackLine reaffirms view FY23 EPS 89c-94c, consensus 92c
- 03/06/23
- BlackLine reaffirms Q1 EPS 15c-17c, consensus 16c
- 02/14/23
- BlackLine sees FY23 EPS 89c-94c, consensus 57c
- 02/14/23
- BlackLine sees Q1 EPS 15c-17c, consensus 11c
- 02/23/23
- BridgeBio reports Q4 EPS (92c), consensus (85c)
- 11/03/22
- BridgeBio reports Q3 EPS (93c), consensus (99c)
- 02/02/23
- Amazon sees Q1 revenue $121B-$126B, consensus $125.11B
- 02/02/23
- Amazon reports Q4 EPS 3c with Rivian loss, consensus 17c
- 02/02/23
- Notable companies reporting after market close
- 10/27/22
- Amazon sees Q4 revenue $140B-$148B, consensus $155.15B
- 03/02/23
- C3.ai sees FY23 revenue $264M-$266M, consensus $261.3M
- 03/02/23
- C3.ai sees Q4 revenue $70M-$72M, consensus $69.85M
- 03/02/23
- C3.ai reports Q3 adjusted EPS (6c), consensus (22c)
- 03/02/23
- Notable companies reporting after market close
ACRS Aclaris Therapeutics - 02/23/23
- Aclaris Therapeutics reports Q4 EPS (41c), consensus (45c)
- 11/08/22
- Aclaris Therapeutics reports Q3 EPS (30c), consensus (40c)
- $155.55 /
+4.465 (+2.96%) - 02/02/23
- Apple reports Q1 EPS $1.88, consensus $1.94
- 10/27/22
- Apple reports Q4 EPS $1.29, consensus $1.17
- 10/27/22
- Notable companies reporting after market close
|
On The Fly
|
Want to get stock-moving… ShowHide Related Items >><< - 03/03/23
- Trian Fund cuts Wendy's stake to 17.85% from 19.52%
- 03/01/23
- Wendy's sees FY23 CapEx $75M-$85M
- 03/01/23
- Wendy's announces plan to redesign organizational structure
- 03/01/23
- Wendy's reports Q4 U.S. systemwide sales growth of 7.2%
- 02/23/23
- Vir Biotechnology shares fall over 5% after missing quarterly estimates
- 02/22/23
- Vir Biotechnology announces final draft guidance on sotrovimab from U.K.'s NICE
- 02/16/23
- Vir Biotechnology appoints Sung Lee as Chief Financial Officer
- 02/13/23
- Vir Biotechnology announces amended collaboration pact with GSK
- 03/06/23
- Silvergate Capital falls -9.6%
- 03/06/23
- Silvergate falls after discontinuing Silvergate Exchange Network
- 03/03/23
- Silvergate Capital falls -6.4%
- 03/02/23
- Silvergate Capital falls -44.7%
- 02/03/23
- RH says certain financial statements 'should no longer be relied upon'
- 02/03/23
- RH sees FY22 revenue growth at low end of prior range of (3.5%)-(4.5%)
- 12/08/22
- RH says Q3 gross margin contracted 50bps
- 12/08/22
- RH to acquire Dmitriy & Co
- 03/02/23
- Cue Health announces new COVID-19 awareness collaboration with Pfizer
- 02/28/23
- Pfizer gets positive FDA AdCom votes for PF-06928316
- 02/24/23
- Pfizer treatment of pulmonary arterial hypertension gets FDA orphan designation
- 02/22/23
- Pfizer's elranatamab receives FDA and EMA filing acceptance
NATI National Instruments - 03/06/23
- National Instruments acquires SET GmbH, terms undisclosed
- 02/16/23
- Meritage Homes initiates quarterly dividend of 27c per share
- 02/01/23
- Meritage Homes reports Q4 EPS $7.09, consensus $7.00
- 10/26/22
- Meritage Homes sees Q4 home closings 4,300-4,700
- 09/29/22
- Meritage Homes releases second annual ESG report
- 03/06/23
- Merck: FDA approves IM route of administration for MMRV family of vaccines
- 03/02/23
- Illumina and Myriad Genetics partner for HRD testing in the U.S.
- 03/02/23
- AstraZeneca says FDA to convene AdCom meeting on sNDA for Lynparza in mCRPC
- 03/01/23
- BeyondSpring enrolls first patient in study of Plinabulin, Keytruda, Docetaxel
- 02/28/23
- Monster Beverage announces 2-for-1 split, effective March 28
- 11/03/22
- Monster Beverage announces new $500M share repurchase program
- 10/27/22
- MSG Sports, MSG Entertainment enter marketing partnership with Monster Energy
- 10/10/22
- VPX Sports, maker of Bang Energy drinks, seeks Chapter 11 bankruptcy protection
- 03/03/23
- Eli Lilly says FDA broadens indication for Verzenio
- 03/01/23
- Eli Lilly cuts insulin prices by 70%, caps out of pocket costs
- 02/23/23
- Nektar reports Phase 2 data on rezpegaldesleukin in lupus
- 02/13/23
- Eli Lilly to supply API for insulin at reduced price to IABL
- 01/11/23
- KB Home falls 5% to $34.20 after Q4 earnings miss and guidance
- 01/11/23
- KB Home sees 2023 housing revenue at $5.0B-$6.0B vs. $6.88B in 2022
- 01/11/23
- KB Home sees Q1 housing revenue at $1.25B-$1.40B
- 01/11/23
- KB Home reports Q4 gross orders down 47%
HR Healthcare Realty Trust - 01/31/23
- Healthcare Realty Trust completes $112.M in asset sales to fund special dividend
- 02/23/23
- HashiCorp exec sells $1.16M in common stock
- 02/01/23
- PowerSchool appoints Paul Brook as CCO
- 12/07/22
- HashiCorp jumps 10% to $29.43 after Q3 earnings beat and guidance raise
- 10/19/22
- Intel announces new cloud collaboration with HashiCorp
- 01/23/23
- Emerson Electric issues statement regarding National Instruments proposal
- 01/17/23
- National Instruments reiterates commitment to strategic review process
- 01/17/23
- National Instruments confirms receipt of acquisition proposal from Emerson
- 01/17/23
- Emerson Electric 'disappointed' National Instruments chose to announce review
- 02/13/23
- Soros Fund buys Horizon Therapeutics, exits BNY Mellon in Q4
- 01/24/23
- D.R. Horton saw 'slight' improvement in cancellation rate in January
- 01/24/23
- D.R. Horton: Goal is to generate FY23 revenue slightly higher than FY22
- 12/15/22
- D.R. Horton acquires homebuilding operations of Riggins Custom Homes
- 03/03/23
- Bristol-Myers receives EC approval of Reblozyl
- 03/02/23
- Bristol-Myers and Johnson & Johnson launch Phase 3 trial of milvexian
- 02/28/23
- Bristol-Myers: FDA accepts sBLA for Opdivo
- 02/17/23
- Bristol-Myers announces three-year results from Phase 3 CheckMate-274 trial
- 02/28/23
- Globalstar spikes 10% after disclosing $252M loan from Apple
- 02/22/23
- Apple prepares to allow outside app stores or 'sideloading,' Bloomberg reports
- 02/16/23
- T-Mobile announces launch of MLS Season Pass on Apple TV app
- 02/14/23
- Berkshire added more of top-holding Apple, Paramount in Q4
- 03/06/23 Redburn
- Monster Beverage upgraded to Buy from Neutral at Redburn
- 03/01/23 BMO Capital
- Monster Beverage price target raised to $105 from $97 at BMO Capital
- 03/01/23 Truist
- Monster Beverage price target raised to $120 from $100 at Truist
- 03/01/23 Citi
- Monster Beverage price target lowered to $118 from $121 at Citi
- 03/06/23 Needham
- Needham upgrades HashiCorp to Buy on conservative 2023 estimates
- 03/06/23 Needham
- HashiCorp upgraded to Buy from Hold at Needham
- 02/24/23 Scotiabank
- HashiCorp initiated with a Sector Perform, $34 target at Scotiabank
- 02/23/23 Scotiabank
- HashiCorp initiated with a Sector Perform at Scotiabank
- 03/06/23 UBS
- Emerson Electric upgraded to Buy from Neutral at UBS
- 02/21/23 TD Cowen
- Emerson Electric price target lowered to $105 from $115 at Cowen
- 02/14/23 Argus
- Argus cuts Emerson Electric to Hold, sees 'problematic' recent trends
- 02/14/23 Argus
- Emerson Electric downgraded to Hold from Buy at Argus
NATI National Instruments - 02/01/23 Baird
- National Instruments downgraded to Neutral from Outperform at Baird
- 01/18/23 Baird
- Aspen Technology price target lowered to $224 from $242 at Baird
- 01/17/23 Deutsche Bank
- Emerson makes hostile bid for National Instruments, says Deutsche Bank
- 03/06/23 JPMorgan
- Meritage Homes upgraded to Overweight from Neutral at JPMorgan
- 11/22/22 JPMorgan
- Meritage Homes price target raised to $90 from $78 at JPMorgan
- 11/14/22 KeyBanc
- Meritage Homes price target raised to $96 from $87 at KeyBanc
- 10/10/22 Wedbush
- Meritage Homes price target lowered to $102 from $130 at Wedbush
- 03/06/23 H.C. Wainwright
- Vir Biotechnology price target lowered to $100 from $125 at H.C. Wainwright
- 03/06/23 JPMorgan
- Vir Biotechnology upgraded to Overweight from Neutral at JPMorgan
- 02/21/23 Goldman Sachs
- Vir Biotechnology upgraded to Buy from Neutral at Goldman Sachs
- 01/27/23 Morgan Stanley
- Vir Biotechnology upgraded to Equal Weight from Underweight at Morgan Stanley
- 03/06/23 Northcoast
- Wendy's downgraded to Neutral at Northcoast on profit headwinds, share risk
- 03/06/23 Northcoast
- Wendy's downgraded to Neutral from Buy at Northcoast
- 01/17/23 Truist
- Wendy's price target raised to $28 from $27 at Truist
- 01/16/23 Deutsche Bank
- Wendy's downgraded to Hold from Buy at Deutsche Bank
- 03/06/23 Jefferies
- RH cut to Hold at Jefferies with luxury housing market 'struggling to stabilize'
- 03/06/23 Jefferies
- RH downgraded to Hold from Buy at Jefferies
- 02/07/23 Barclays
- Barclays sees a 'reset' in U.S. retail but 'not a recession yet'
- 02/07/23 Barclays
- RH assumed with an Equal Weight at Barclays
- 03/06/23 Compass Point
- Silvergate Capital downgraded to Sell from Neutral at Compass Point
- 03/06/23 Wedbush
- Wedbush downgrades Silvergate Capital to Underperform, lowers price target to $4
- 03/06/23 Wedbush
- Silvergate Capital downgraded to Underperform from Neutral at Wedbush
- 03/02/23 Goldman Sachs
- Goldman suspends Silvergate rating on 'insufficient information'
- 03/06/23 JPMorgan
- D.R. Horton downgraded to Neutral from Overweight at JPMorgan
- 01/25/23 BTIG
- D.R. Horton price target raised to $108 from $101 at BTIG
- 01/25/23 JMP Securities
- D.R. Horton price target raised to $115 from $95 at JMP Securities
- 01/25/23 Wedbush
- Wedbush downgrades D.R. Horton to Neutral, lowers price target to $96
- 03/06/23 JPMorgan
- KB Home downgraded to Underweight from Overweight at JPMorgan
- 01/13/23 BTIG
- KB Home earnings miss driven by fewer deliveries, says BTIG
- 01/13/23 RBC Capital
- KB Home downgraded to Sector Perform from Outperform at RBC Capital
- 01/12/23 UBS
- KB Home price target lowered to $45 from $48 at UBS
HR Healthcare Realty Trust - 03/06/23 Credit Suisse
- Healthcare Realty Trust downgraded to Neutral from Outperform at Credit Suisse
- 01/30/23 Citi
- Citi opens 'Catalyst Watches' into REITs, lodging earnings reports
- 12/14/22 Citi
- Healthcare Realty Trust downgraded to Neutral from Buy at Citi
- 11/10/22 Barclays
- Healthcare Realty Trust price target lowered to $28 from $33 at Barclays
- 03/06/23 BofA
- Apple App Store revenue growth 'still muted' in fiscal Q2-to-date, says BofA
- 03/05/23 Goldman Sachs
- Apple initiated with a Buy at Goldman Sachs
- 03/03/23 Barclays
- Google facing query share loss for first time ever, says Barclays
- 03/03/23 Morgan Stanley
- Morgan Stanley sees catalysts for top pick Apple, ups price target
- 03/06/23 Jefferies
- Jefferies starts 'optically cheap' Bristol-Myers at Hold on structural concerns
- 03/06/23 Jefferies
- Bristol-Myers initiated with a Hold at Jefferies
- 01/19/23 Piper Sandler
- Amgen price target cut at Piper on lower Otezla estimates
- 01/17/23 Cantor Fitzgerald
- Bristol-Myers initiated with an Overweight at Cantor Fitzgerald
- 03/06/23 Jefferies
- Jefferies starts Pfizer with a Hold on lack of visibility
- 03/06/23 Jefferies
- Pfizer initiated with a Hold at Jefferies
- 03/03/23 SVB Securities
- SVB says Pfizer could create value for holders with Seagen bid up to $253
- 02/28/23 Oppenheimer
- Seagen price target raised to $210 from $180 at Oppenheimer
- 03/06/23 Jefferies
- Jefferies starts 'priced to perfection' Eli Lilly with a Hold
- 03/06/23 Jefferies
- Eli Lilly initiated with a Hold at Jefferies
- 03/02/23 Morgan Stanley
- Novo Nordisk named 'Catalyst Driven Idea' at Morgan Stanley
- 02/24/23 Jefferies
- Nektar downgraded to Underperform from Hold at Jefferies
- 03/06/23 Jefferies
- Merck initiated with a Buy at Jefferies
- 02/23/23 JPMorgan
- Merck shares positioned for further upside, says JPMorgan
- 02/22/23 Wolfe Research
- Wolfe upgrades Merck with pipeline 'big enough to matter'
- 03/01/23
- Wendy's sees FY23 adjusted EPS 95c-$1.00, consensus $1.00
- 03/01/23
- Wendy's reports Q4 adjusted EPS 22c, consensus 20c
- 02/28/23
- Notable companies reporting before tomorrow's open
- 02/23/23
- Vir Biotechnology reports Q4 EPS (76c), consensus (39c)
- 11/03/22
- Vir Biotechnology reports Q3 EPS $1.30, consensus (21c)
- 01/17/23
- Silvergate Capital reports Q4 adjusted EPS 48c, consensus 81c
- 10/18/22
- Silvergate Capital reports Q3 EPS $1.28, consensus $1.38
- 12/08/22
- RH narrow FY22 revenue growth view to down 4.5% to down 3.5%
- 12/08/22
- RH reports Q3 EPS $5.67, consensus $4.70
- 12/08/22
- Notable companies reporting after market close
- 09/08/22
- RH sees Q3 revenue down 18% to down 15%
- 01/31/23
- Pfizer sees FY23 adjusted EPS $3.25-$3.45, consensus $4.44
- 01/31/23
- Pfizer reports Q4 adjusted EPS $1.14, consensus $1.05
- 01/30/23
- Notable companies reporting before tomorrow's open
NATI National Instruments - 01/31/23
- National Instruments sees Q1 adjusted EPS 48c-62c, consensus 47c
- 01/31/23
- National Instruments reports Q4 adjusted EPS 63c, consensus 64c
- 10/27/22
- National Instruments sees Q4 non-GAP EPS 54c-68c, consensus 76c
- 10/27/22
- National Instruments reports Q3 non-GAAP EPS 53c, consensus 53c
- 10/26/22
- Meritage Homes sees Q4 adjusted EPS $6.50-$7.40, consensus $6.92
- 10/26/22
- Meritage Homes reports Q3 EPS $7.10, consensus $6.45
- 02/28/23
- NGM Biopharmaceuticals reports Q4 EPS (45c), consensus (51c)
- 02/02/23
- Merck sees FY23 adjusted EPS $6.80-$6.95, consensus $7.36
- 02/02/23
- Merck reports Q4 adjusted EPS $1.62, consensus $1.54
- 02/28/23
- Monster Beverage reports Q4 EPS 57c, consensus 63c
- 02/28/23
- Notable companies reporting after market close
- 11/03/22
- Monster Beverage reports Q3 EPS 60c, consensus 59c
- 11/03/22
- Notable companies reporting after market close
- 02/02/23
- Eli Lilly raises FY23 adjusted EPS view to $8.35-$8.55 from $8.10-$8.30
- 02/02/23
- Eli Lilly reports Q4 adjusted EPS $2.09, consensus $1.78
- 01/11/23
- KB Home reports Q4 EPS $2.47, consensus $2.87
- 09/21/22
- KB Home sees Q4 housing revenue $1.95B-$2.05B
- 09/21/22
- KB Home reports Q3 EPS $2.86, consensus $2.67
- 09/21/22
- Notable companies reporting after market close
HR Healthcare Realty Trust - 03/01/23
- Healthcare Realty Trust reports Q4 normalized FFO 42c, consensus 40c
- 11/09/22
- Healthcare Realty Trust reports Q3 normalized FFO 39c, consensus 42c
- 12/07/22
- HashiCorp raises FY23 EPS view to (71c)-(69c) from (97c)-(95c), consensus (96c)
- 12/07/22
- HashiCorp sees Q4 EPS (23c)-(21c), consensus (30c)
- 12/07/22
- HashiCorp reports Q3 EPS (13c), consensus (31c)
- 02/08/23
- Emerson Electric backs FY23 adjusted EPS view $4.00-$4.15, consensus $4.08
- 02/08/23
- Emerson Electric sees Q2 adjusted EPS 95c-$1.00, consensus $1.00
- 02/08/23
- Emerson Electric reports Q1 adjusted EPS 78c, consensus 88c
- 10/31/22
- Emerson Electric sees FY23 adjusted EPS $4.00-$4.15, consensus $5.08
- 01/24/23
- D.R. Horton sees Q2 revenue $6.3B-$6.7B, consensus $6.53B
- 01/24/23
- D.R. Horton reports Q1 EPS $2.76, consensus $2.26
- 01/23/23
- Notable companies reporting before tomorrow's open
- 02/02/23
- Bristol-Myers sees FY23 adjusted EPS $7.95-$8.25, consensus $8.00
- 02/02/23
- Bristol-Myers reports Q4 adjusted EPS $1.82, consensus $1.72
- 02/01/23
- Notable companies reporting before tomorrow's open
- 02/02/23
- Apple reports Q1 EPS $1.88, consensus $1.94
- 02/02/23
- Notable companies reporting after market close
- 10/27/22
- Apple reports Q4 EPS $1.29, consensus $1.17
- 10/27/22
- Notable companies reporting after market close
- 09/16/22
- WHO panel recommends against GSK, Regeneron COVID drugs, Bloomberg reports
- 03/03/23
- Silvergate Capital suspending Silvergate exchange network, Bloomberg says
- 03/03/23
- FHLB says Silvergate advances 'fully repaid,' American Banker reports
- 03/02/23
- Coinbase, Galaxy drop Silvergate after going concern filing, Reuters reports
- 02/16/23
- Binance had secret access to U.S. partner account at Silvergate, Reuters says
- 02/28/23
- FDA advisors back safety of Pfizer RSV vaccine
- 02/27/23
- Pfizer in talks to buy Seagen in deal that may be valued at over $30B, WSJ says
- 02/04/23
- Pfizer stock a buy as company moves beyond COVID, Barron's says
- 02/01/23
- Novavax refuses to refund $700M for COVID shots never delivered, NY Times says
- 01/13/23
- Johnson & Johnson cuts production of Covid-19 vaccine, WSJ reports
- 01/11/23
- Merck, Pfizer rebuff China's efforts to cut Covid drug prices, Bloomberg says
- 12/30/22
- Merck's Covid treatment gets conditional approval in China, Reuters reports
- 09/30/22
- Jury awards $293M in damages to Monster from rival Bang Energy, Reuters reports
- 03/06/23
- New diabetes drugs altering how patients are treated, WSJ reports
- 12/19/22
- Eli Lilly's Mounjaro, Trulicity added to FDA shortage list, STATNews reports
- 10/11/22
- New quality issues found at Eli Lilly drug plant, Reuters reports
- 12/27/22
- Changes at Disney, a Stitch Fix deal among The Information's 2023 predictions
- 10/31/22
- Blackstone to buy 55% stake in Emerson unit in $14B deal, WSJ reports
- 10/04/22
- Blackstone in talks to acquire select Emerson assets, Bloomberg says
- 10/04/22
- Blackstone in talks to acquire select Emerson assets, Bloomberg says
- 11/12/22
- Housing stocks have rallied, but could start falling again, Barron's says
- 01/04/23
- Aurinia worth 'keeping closer eye on' after settlement, Dealreporter says
- 10/20/22
- Drugmakers look to limit Medicare's power to negotiate drug prices, WSJ reports
- 03/03/23
- Apple executive in charge of cloud initiatives stepping down, Bloomberg reports
- 03/03/23
- Foxconn plans $700M investment in India plant, Bloomberg reports
- 03/02/23
- ESPN looking to be hub of all live sports streaming, CNBC reports
- 03/02/23
- 2023 iPhone to be powered by TSMC's 3nm SoC, DigiTimes reports
- 03/01/23
- Fly Intel: Pre-market Movers
- 03/06/23
- Fly Intel: Pre-market Movers
- 02/21/23
- What You Missed On Wall Street On Tuesday
- 02/21/23
- What You Missed On Wall Street This Morning
- 03/03/23
- Here's What You Missed in Crypto This Week
- 03/02/23
- What You Missed On Wall Street On Thursday
- 02/06/23
- What You Missed On Wall Street On Monday
- 02/06/23
- What You Missed On Wall Street This Morning
- 02/06/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/27/23
- What You Missed On Wall Street On Monday
- 02/27/23
- What You Missed On Wall Street This Morning
- 02/27/23
- Fly Intel: Pre-market Movers
NATI National Instruments - 01/17/23
- What You Missed On Wall Street This Morning
- 01/13/23
- What You Missed On Wall Street On Friday
- 09/19/22
- What You Missed On Wall Street On Monday
- 09/19/22
- What You Missed On Wall Street This Morning
- 09/19/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/25/23
- Buy/Sell: Wall Street's top 10 stock calls this week
- 02/23/23
- What You Missed On Wall Street On Thursday
- 02/23/23
- What You Missed On Wall Street This Morning
- 03/06/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 03/01/23
- What You Missed On Wall Street On Wednesday
- 03/01/23
- What You Missed On Wall Street This Morning
- 02/28/23
- Fly Intel: After-Hours Movers
- 02/02/23
- What You Missed On Wall Street On Thursday
- 02/02/23
- What You Missed On Wall Street This Morning
- 01/13/23
- What You Missed On Wall Street This Morning
- 01/12/23
- Fly Intel: Pre-market Movers
- 02/24/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/13/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/08/22
- What You Missed On Wall Street On Thursday
- 02/08/23
- What You Missed On Wall Street This Morning
- 02/08/23
- Fly Intel: Pre-market Movers
- 01/17/23
- What You Missed On Wall Street On Tuesday
- 01/24/23
- What You Missed On Wall Street On Tuesday
- 01/24/23
- What You Missed On Wall Street This Morning
- 11/09/22
- Fly Intel: Pre-market Movers
- 02/02/23
- Fly Intel: Pre-market Movers
- 01/17/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/21/22
- Biotech Alert: Searches spiking for these stocks today
- 03/03/23
- Fly Intel: Pre-market Movers
- 03/01/23
- #SocialStocks: Meta leverages artificial intelligence throughout subsidiaries
- 09/12/22
- Wendy's call buyer realizes 30% same-day gains
- 03/06/23
- Unusually active option classes on open March 6th
- 03/06/23
- Notable open interest changes for March 6th
- 03/03/23
- Notable open interest changes for March 3rd
- 02/15/23
- Silvergate Capital Corp call volume above normal and directionally bullish
- 02/08/23
- Largest borrow rate increases among liquid names
- 12/08/22
- Restoration Hardware options imply 7.8% move in share price post-earnings
- 10/24/22
- Restoration Hardware put volume heavy and directionally bearish
- 09/08/22
- Restoration Hardware options imply 7.3% move in share price post-earnings
- 01/31/23
- Unusually active option classes on open January 31st
- 01/11/23
- Largest borrow rate increases among liquid names
- 01/10/23
- Unusually active option classes on open January 10th
- 11/14/22
- Pfizer call volume above normal and directionally bullish
NATI National Instruments - 03/01/23
- National Instruments call volume above normal and directionally bullish
- 01/10/23
- Largest borrow rate increases among liquid names
- 12/07/22
- Largest borrow rate increases among liquid names
- 11/14/22
- Early notable gainers among liquid option names on November 14th
- 10/10/22
- Early notable gainers among liquid option names on October 10th
- 03/02/23
- Early notable gainers among liquid option names on March 2nd
- 11/01/22
- Unusually active option classes on open November 1st
- 10/03/22
- Eli Lilly And Co put volume heavy and directionally bearish
- 09/28/22
- Early notable gainers among liquid option names on September 28th
- 09/28/22
- Unusually active option classes on open September 28th
- 02/09/23
- Unusually active option classes on open February 9th
- 02/08/23
- KB Home put volume heavy and directionally bearish
- 01/11/23
- KB Home options imply 4.2% move in share price post-earnings
- 12/07/22
- KB Home put volume heavy and directionally bearish
- 12/07/22
- Hashicorp options imply 11.3% move in share price post-earnings
- 02/17/23
- D R Horton put volume heavy and directionally bearish
- 02/03/23
- D R Horton put volume heavy and directionally bearish
- 01/19/23
- D R Horton put volume heavy and directionally bearish
- 11/09/22
- Early notable gainers among liquid option names on November 9th
- 02/24/23
- Bristol Myers Squibb put volume heavy and directionally bearish
- 09/29/22
- Early notable gainers among liquid option names on September 29th
- 09/12/22
- Early notable gainers among liquid option names on September 12th
- 09/12/22
- Unusually active option classes on open September 12th
- 03/02/23
- Notable open interest changes for March 2nd
- 03/01/23
- Notable open interest changes for March 1st
- 02/28/23
- Notable open interest changes for February 28th
|
Downgrade
|
Jefferies downgraded RH… Jefferies downgraded RH to Hold from Buy with a $298 price target. The luxury housing market is "struggling to stabilize" even before corporate cuts to headcount and compensation have "rippled across the luxury home furnishings category," said the firm. Jefferies is moving to the sidelines as it sees more risk than reward heading into 2023 guidance from RH. ShowHide Related Items >><< - $297.25 /
+4.325 (+1.48%) - 02/03/23
- RH says certain financial statements 'should no longer be relied upon'
- 02/03/23
- RH sees FY22 revenue growth at low end of prior range of (3.5%)-(4.5%)
- 12/08/22
- RH says Q3 gross margin contracted 50bps
- 12/08/22
- RH to acquire Dmitriy & Co
- $297.25 /
+4.325 (+1.48%) - 03/06/23 Jefferies
- RH downgraded to Hold from Buy at Jefferies
- 02/07/23 Barclays
- Barclays sees a 'reset' in U.S. retail but 'not a recession yet'
- 02/07/23 Barclays
- RH assumed with an Equal Weight at Barclays
- 02/06/23 Wedbush
- RH price target raised to $335 from $270 at Wedbush
- $297.25 /
+4.325 (+1.48%) - 12/08/22
- RH narrow FY22 revenue growth view to down 4.5% to down 3.5%
- 12/08/22
- RH reports Q3 EPS $5.67, consensus $4.70
- 12/08/22
- Notable companies reporting after market close
- 09/08/22
- RH sees Q3 revenue down 18% to down 15%
- $297.25 /
+4.325 (+1.48%) - 02/06/23
- What You Missed On Wall Street On Monday
- 02/06/23
- What You Missed On Wall Street This Morning
- 02/06/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/13/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- $297.25 /
+4.325 (+1.48%) - 02/08/23
- Largest borrow rate increases among liquid names
- 12/08/22
- Restoration Hardware options imply 7.8% move in share price post-earnings
- 10/24/22
- Restoration Hardware put volume heavy and directionally bearish
- 09/08/22
- Restoration Hardware options imply 7.3% move in share price post-earnings
|
Downgrade
|
Jefferies analyst… Jefferies analyst Jonathan Matuszewski downgraded RH to Hold from Buy with a $298 price target. ShowHide Related Items >><< - $297.25 /
+4.325 (+1.48%) - 02/03/23
- RH says certain financial statements 'should no longer be relied upon'
- 02/03/23
- RH sees FY22 revenue growth at low end of prior range of (3.5%)-(4.5%)
- 12/08/22
- RH says Q3 gross margin contracted 50bps
- 12/08/22
- RH to acquire Dmitriy & Co
- $297.25 /
+4.325 (+1.48%) - 02/07/23 Barclays
- Barclays sees a 'reset' in U.S. retail but 'not a recession yet'
- 02/07/23 Barclays
- RH assumed with an Equal Weight at Barclays
- 02/06/23 Wedbush
- RH price target raised to $335 from $270 at Wedbush
- 02/06/23 Telsey Advisory
- RH downgraded to Market Perform at Telsey Advisory following 29% rally
- $297.25 /
+4.325 (+1.48%) - 12/08/22
- RH narrow FY22 revenue growth view to down 4.5% to down 3.5%
- 12/08/22
- RH reports Q3 EPS $5.67, consensus $4.70
- 12/08/22
- Notable companies reporting after market close
- 09/08/22
- RH sees Q3 revenue down 18% to down 15%
- $297.25 /
+4.325 (+1.48%) - 02/06/23
- What You Missed On Wall Street On Monday
- 02/06/23
- What You Missed On Wall Street This Morning
- 02/06/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/13/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- $297.25 /
+4.325 (+1.48%) - 02/08/23
- Largest borrow rate increases among liquid names
- 12/08/22
- Restoration Hardware options imply 7.8% move in share price post-earnings
- 10/24/22
- Restoration Hardware put volume heavy and directionally bearish
- 09/08/22
- Restoration Hardware options imply 7.3% move in share price post-earnings
|
Conference/Events
|
Consumer Goods Analyst… Consumer Goods Analyst Rakhlenko and Loshin provide a preview of the Furniture Industry (RH, Williams-Sonoma) on an Analyst/Industry conference call to be held on March 3 at 11 am. Webcast Link ShowHide Related Items >><< - $124.20 /
+0.865 (+0.70%) - 01/30/23
- Williams-Sonoma appoints Marta Benson as CEO, Pottery Barn Brands
- 11/18/22
- Williams-Sonoma falls -9.7%
- 11/17/22
- Williams-Sonoma falls 11% to $116.15 after Q3 results
- 11/17/22
- Williams-Sonoma backs FY22 guidance of mid-to-high single digit revenue growth
- 02/03/23
- RH says certain financial statements 'should no longer be relied upon'
- 02/03/23
- RH sees FY22 revenue growth at low end of prior range of (3.5%)-(4.5%)
- 12/08/22
- RH says Q3 gross margin contracted 50bps
- 12/08/22
- RH to acquire Dmitriy & Co
- 02/07/23 Barclays
- Barclays sees a 'reset' in U.S. retail but 'not a recession yet'
- 02/07/23 Barclays
- RH assumed with an Equal Weight at Barclays
- 02/06/23 Wedbush
- RH price target raised to $335 from $270 at Wedbush
- 02/06/23 Telsey Advisory
- RH downgraded to Market Perform at Telsey Advisory following 29% rally
- $124.20 /
+0.865 (+0.70%) - 02/07/23 Barclays
- Williams-Sonoma assumed with an Equal Weight at Barclays
- 12/13/22 Needham
- Williams-Sonoma initiated with a Hold at Needham
- 11/28/22 Morgan Stanley
- Williams-Sonoma downgraded to Underweight from Equal Weight at Morgan Stanley
- $124.20 /
+0.865 (+0.70%) - 11/17/22
- Williams-Sonoma reports Q3 EPS $3.72, consensus $3.71
- 11/17/22
- Notable companies reporting after market close
- 12/08/22
- RH narrow FY22 revenue growth view to down 4.5% to down 3.5%
- 12/08/22
- RH reports Q3 EPS $5.67, consensus $4.70
- 12/08/22
- Notable companies reporting after market close
- 09/08/22
- RH sees Q3 revenue down 18% to down 15%
- $124.20 /
+0.865 (+0.70%) - 12/03/22
- Buy/Sell: Wall Street's top 10 stock calls this week
- 11/28/22
- What You Missed On Wall Street On Monday
- 11/28/22
- What You Missed On Wall Street This Morning
- 02/06/23
- What You Missed On Wall Street On Monday
- 02/06/23
- What You Missed On Wall Street This Morning
- 02/06/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/13/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- $124.20 /
+0.865 (+0.70%) - 11/17/22
- Williams Sonoma options imply 8.0% move in share price post-earnings
- 09/30/22
- Unusually active option classes on open September 30th
- 02/08/23
- Largest borrow rate increases among liquid names
- 12/08/22
- Restoration Hardware options imply 7.8% move in share price post-earnings
- 10/24/22
- Restoration Hardware put volume heavy and directionally bearish
- 09/08/22
- Restoration Hardware options imply 7.3% move in share price post-earnings
|
Conference/Events
|
Consumer Goods Analyst… Consumer Goods Analyst Rakhlenko and Loshin provide a preview of the Furniture Industry (RH, Williams-Sonoma) on an Analyst/Industry conference call to be held on March 3 at 11 am. Webcast Link ShowHide Related Items >><< - 01/30/23
- Williams-Sonoma appoints Marta Benson as CEO, Pottery Barn Brands
- 11/18/22
- Williams-Sonoma falls -9.7%
- 11/17/22
- Williams-Sonoma falls 11% to $116.15 after Q3 results
- 11/17/22
- Williams-Sonoma backs FY22 guidance of mid-to-high single digit revenue growth
- 02/03/23
- RH says certain financial statements 'should no longer be relied upon'
- 02/03/23
- RH sees FY22 revenue growth at low end of prior range of (3.5%)-(4.5%)
- 12/08/22
- RH says Q3 gross margin contracted 50bps
- 12/08/22
- RH to acquire Dmitriy & Co
- 02/07/23 Barclays
- Barclays sees a 'reset' in U.S. retail but 'not a recession yet'
- 02/07/23 Barclays
- RH assumed with an Equal Weight at Barclays
- 02/06/23 Wedbush
- RH price target raised to $335 from $270 at Wedbush
- 02/06/23 Telsey Advisory
- RH downgraded to Market Perform at Telsey Advisory following 29% rally
- 02/07/23 Barclays
- Williams-Sonoma assumed with an Equal Weight at Barclays
- 12/13/22 Needham
- Williams-Sonoma initiated with a Hold at Needham
- 11/28/22 Morgan Stanley
- Williams-Sonoma downgraded to Underweight from Equal Weight at Morgan Stanley
- 11/17/22
- Williams-Sonoma reports Q3 EPS $3.72, consensus $3.71
- 11/17/22
- Notable companies reporting after market close
- 12/08/22
- RH narrow FY22 revenue growth view to down 4.5% to down 3.5%
- 12/08/22
- RH reports Q3 EPS $5.67, consensus $4.70
- 12/08/22
- Notable companies reporting after market close
- 09/08/22
- RH sees Q3 revenue down 18% to down 15%
- 12/03/22
- Buy/Sell: Wall Street's top 10 stock calls this week
- 11/28/22
- What You Missed On Wall Street On Monday
- 11/28/22
- What You Missed On Wall Street This Morning
- 02/06/23
- What You Missed On Wall Street On Monday
- 02/06/23
- What You Missed On Wall Street This Morning
- 02/06/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/13/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/17/22
- Williams Sonoma options imply 8.0% move in share price post-earnings
- 09/30/22
- Unusually active option classes on open September 30th
- 02/08/23
- Largest borrow rate increases among liquid names
- 12/08/22
- Restoration Hardware options imply 7.8% move in share price post-earnings
- 10/24/22
- Restoration Hardware put volume heavy and directionally bearish
- 09/08/22
- Restoration Hardware options imply 7.3% move in share price post-earnings
|
Conference/Events
|
Consumer Goods Analyst… Consumer Goods Analyst Rakhlenko and Loshin provide a preview of the Furniture Industry (RH, Williams-Sonoma) on an Analyst/Industry conference call to be held on March 3 at 11 am. Webcast Link ShowHide Related Items >><< - $123.54 /
-1.555 (-1.24%) - 01/30/23
- Williams-Sonoma appoints Marta Benson as CEO, Pottery Barn Brands
- 11/18/22
- Williams-Sonoma falls -9.7%
- 11/17/22
- Williams-Sonoma falls 11% to $116.15 after Q3 results
- 11/17/22
- Williams-Sonoma backs FY22 guidance of mid-to-high single digit revenue growth
- 02/03/23
- RH says certain financial statements 'should no longer be relied upon'
- 02/03/23
- RH sees FY22 revenue growth at low end of prior range of (3.5%)-(4.5%)
- 12/08/22
- RH says Q3 gross margin contracted 50bps
- 12/08/22
- RH to acquire Dmitriy & Co
- 02/07/23 Barclays
- Barclays sees a 'reset' in U.S. retail but 'not a recession yet'
- 02/07/23 Barclays
- RH assumed with an Equal Weight at Barclays
- 02/06/23 Wedbush
- RH price target raised to $335 from $270 at Wedbush
- 02/06/23 Telsey Advisory
- RH downgraded to Market Perform at Telsey Advisory following 29% rally
- $123.54 /
-1.555 (-1.24%) - 02/07/23 Barclays
- Williams-Sonoma assumed with an Equal Weight at Barclays
- 12/13/22 Needham
- Williams-Sonoma initiated with a Hold at Needham
- 11/28/22 Morgan Stanley
- Williams-Sonoma downgraded to Underweight from Equal Weight at Morgan Stanley
- $123.54 /
-1.555 (-1.24%) - 11/17/22
- Williams-Sonoma reports Q3 EPS $3.72, consensus $3.71
- 11/17/22
- Notable companies reporting after market close
- 12/08/22
- RH narrow FY22 revenue growth view to down 4.5% to down 3.5%
- 12/08/22
- RH reports Q3 EPS $5.67, consensus $4.70
- 12/08/22
- Notable companies reporting after market close
- 09/08/22
- RH sees Q3 revenue down 18% to down 15%
- $123.54 /
-1.555 (-1.24%) - 12/03/22
- Buy/Sell: Wall Street's top 10 stock calls this week
- 11/28/22
- What You Missed On Wall Street On Monday
- 11/28/22
- What You Missed On Wall Street This Morning
- 02/06/23
- What You Missed On Wall Street On Monday
- 02/06/23
- What You Missed On Wall Street This Morning
- 02/06/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/13/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- $123.54 /
-1.555 (-1.24%) - 11/17/22
- Williams Sonoma options imply 8.0% move in share price post-earnings
- 09/30/22
- Unusually active option classes on open September 30th
- 02/08/23
- Largest borrow rate increases among liquid names
- 12/08/22
- Restoration Hardware options imply 7.8% move in share price post-earnings
- 10/24/22
- Restoration Hardware put volume heavy and directionally bearish
- 09/08/22
- Restoration Hardware options imply 7.3% move in share price post-earnings
|